• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

HYDERABAD: Avon Organics Ltd (AOL), the city-based pharmaceutical company, is planning to introduce two high value added intermediates in its Diketene division.

In a release to the stock exchanges, the company said these products find application in pharmaceutical sector. According to the company, it has already completed trial production and is ready for commercial launch. The company said it estimates to achieve an additional turnover of Rs 12 crore per annum from these products from 2005-06 onwards.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
ONGC to expand Tripura capacity

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line